Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$980,850
+$269,472 QoQ
Shares Held
40,733
+60.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,338
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 47%
Shared 0%
None 53%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Baker Avenue Asset Management, LP holds $87,152,887 across 10 Drug Manufacturers - General names. PFE ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,531 | $31,822,079 | |
| 2 | ABBV |
AbbVie Inc.
|
85,535 | $21,524,027 | |
| 3 | JNJ |
Johnson & Johnson
|
43,298 | $10,996,393 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
59,347 | $7,497,899 | |
| 5 | MRK |
Merck & Co., Inc.
|
51,784 | $6,654,244 | |
| 6 | AMGN |
Amgen Inc
|
15,621 | $5,656,676 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,475 | $1,006,909 | |
| 8 | PFE |
Pfizer Inc
This page
|
40,733 | $980,850 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $980,850 | 40,733 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $711,378 | 25,334 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $587,689 | 23,602 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $681,844 | 26,760 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $634,045 | 26,157 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $727,942 | 28,727 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $693,255 | 26,131 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $950,968 | 32,860 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $842,813 | 30,122 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $835,358 | 30,103 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $707,485 | 24,574 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,124,993 | 33,916 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,175,227 | 32,040 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,382,793 | 33,892 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,653,975 | 32,279 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,589,932 | 36,333 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,079,690 | 20,593 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,147,326 | 22,162 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,425,230 | 24,136 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $540,291 | 12,562 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $300,787 | 7,681 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $586,455 | 16,187 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $582,849 | 15,834 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $638,395 | 17,395 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $569,274 | 17,409 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $577,857 | 17,704 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||